Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma.

Benzer Materyaller

• Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma
  Yazar:: Druce, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Preliminary Report of the Use of Everolimus in a Patient with Progressive Medullary Thyroid Carcinoma
  Yazar:: Druce, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
  Yazar:: Grozinsky-Glasberg, S, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells
  Yazar:: Grozinsky-Glasberg, S, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• MEDULLARY THYROID CARCINOMA
  Yazar:: V. S. Medvedev, ve diğerleri
  Baskı/Yayın Bilgisi: (2015-04-01)